The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter
ARIAD Pharmaceuticals Inc (ARIA)

ARIAD Pharmaceuticals is an oncology company. Co. is commercializing or developing the following three products and product candidates: Iclusig® (ponatinib), a cancer medicine that Co. is commercializing in the U.S., Europe and other territories for the treatment of certain patients with rare forms of leukemia; Brigatinib, a drug candidate that Co. is developing for the treatment of certain patients with a form of non-small cell lung cancer (NSCLC); and AP32788, a drug candidate that Co. is developing for the treatment of patients with NSCLC with specific mutations in the epidermal growth factor receptor or human epidermal growth factor receptor 2 kinases.

ARIA SEC Filing Email Alerts Service

Company Name:  ARIAD Pharmaceuticals Inc
Sector:  Biotechnology
Number of ETFs Holding ARIA:  27
Total Market Value Held by ETFs:  $123.83M
Total Market Capitalization:  $2.08B
% of Market Cap. Held by ETFs:  5.96%
October 24, 2016    9:16 PM Eastern

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Buy (3.14 out of 4)
53rd percentile
(ranked higher than approx. 53% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

ARIAD Pharmaceuticals Inc (ARIA) Page | The Online Investor | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.